U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) Director Nancy Ham sold 1,172 shares of the company's stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now owns 1,112 shares in the company, valued at $107,552.64. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
U.S. Physical Therapy Price Performance
U.S. Physical Therapy stock opened at $92.17 on Wednesday. U.S. Physical Therapy, Inc. has a 52 week low of $76.18 and a 52 week high of $113.63. The company's 50 day moving average price is $83.92 and its two-hundred day moving average price is $91.25. The stock has a market cap of $1.39 billion, a P/E ratio of 98.05, a P/E/G ratio of 4.28 and a beta of 1.38. The company has a quick ratio of 1.88, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). The business had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business's revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.76 earnings per share. On average, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.
U.S. Physical Therapy Announces Dividend
Tesla Execs are Freaking Out
From Angel Publishing | Ad
It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it.
And Elon Musk has completely restructured Tesla to chase this opportunity.
This is a once-in-a-lifetime opportunity that you don’t want to miss.
Click here to get the details.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy's payout ratio is 187.23%.
Hedge Funds Weigh In On U.S. Physical Therapy
A number of hedge funds and other institutional investors have recently made changes to their positions in USPH. Intech Investment Management LLC bought a new position in shares of U.S. Physical Therapy during the 3rd quarter worth $356,000. First Horizon Advisors Inc. boosted its position in U.S. Physical Therapy by 25.1% during the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company's stock worth $126,000 after purchasing an additional 298 shares during the period. Howe & Rusling Inc. raised its position in shares of U.S. Physical Therapy by 22.5% in the third quarter. Howe & Rusling Inc. now owns 4,864 shares of the company's stock valued at $412,000 after purchasing an additional 893 shares during the period. Quest Partners LLC lifted its stake in shares of U.S. Physical Therapy by 2,368.2% during the 3rd quarter. Quest Partners LLC now owns 8,614 shares of the company's stock valued at $729,000 after buying an additional 8,265 shares in the last quarter. Finally, Sugar Maple Asset Management LLC bought a new position in U.S. Physical Therapy in the 3rd quarter worth approximately $212,000.
Analyst Upgrades and Downgrades
USPH has been the subject of several analyst reports. Bank of America reissued a "neutral" rating and issued a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Wednesday, August 21st. Finally, Barrington Research reaffirmed an "outperform" rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 7th.
Check Out Our Latest Stock Analysis on USPH
U.S. Physical Therapy Company Profile
(
Get Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
